These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6152028)

  • 1. 5-HT and anxiety.
    Iversen SD
    Neuropharmacology; 1984 Dec; 23(12B):1553-60. PubMed ID: 6152028
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
    Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some behavioral effects of serotonin depletion depend on method: a comparison of 5,7-dihydroxytryptamine, p-chlorophenylalanine, p-choloroamphetamine, and electrolytic raphe lesions.
    Lorens SA
    Ann N Y Acad Sci; 1978 Jun; 305():532-55. PubMed ID: 152081
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding.
    Nazar M; Siemiatkowski M; Bidziński A; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
    J Neural Transm (Vienna); 1999; 106(5-6):355-68. PubMed ID: 10443543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
    Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT and anxiety: promises and pitfalls.
    Johnston AL; File SE
    Pharmacol Biochem Behav; 1986 May; 24(5):1467-70. PubMed ID: 2873592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurochemical aspects of the emotional reactivity and motor activity of rats in new circumstances].
    Kulagin DA; Bolondinskiĭ VK
    Usp Fiziol Nauk; 1986; 17(1):92-109. PubMed ID: 2420084
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward.
    Fletcher PJ; Korth KM; Chambers JW
    Psychopharmacology (Berl); 1999 Dec; 147(3):291-9. PubMed ID: 10639688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
    Płaźnik A; Kostowski W; Stefański R
    Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative importance of dopamine and norepinephrine in mediating locomotor activity.
    Fishman RH; Feigenbaum JJ; Yanai J; Klawans HL
    Prog Neurobiol; 1983; 20(1-2):55-88. PubMed ID: 6141594
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.
    King MV; Spicer CH; Sleight AJ; Marsden CA; Fone KC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):111-23. PubMed ID: 18839151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of serotonergic affect control.
    Kennett GA
    Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
    [No Abstract]   [Full Text] [Related]  

  • 15. [The characteristics of the anxiolytic action of taftsin and its analog TP-7 on behavior and serotonin metabolism in the brain of rats with chronic deprivation of serotoninergic system activity].
    Seredenin SB; Semenova TP; Kozlovskaia MM; Medvinskaia NI; Nezovibat'ko VN
    Eksp Klin Farmakol; 1995; 58(6):3-6. PubMed ID: 8704608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat.
    Olausson P; Akesson P; Petersson A; Engel JA; Söderpalm B
    Psychopharmacology (Berl); 2001 Jun; 155(4):348-61. PubMed ID: 11441424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons.
    Fuxe K; Ogren SO; Agnati LF; Jonsson G; Gustafsson JA
    Ann N Y Acad Sci; 1978 Jun; 305():346-69. PubMed ID: 280251
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test.
    Shimizu H; Tatsuno T; Tanaka H; Hirose A; Araki Y; Nakamura M
    Jpn J Pharmacol; 1992 May; 59(1):105-12. PubMed ID: 1354771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.